Table 2. Study-Level Reoperation Rates Stratified by Studies of Actual vs Projected Changes.
Source | Preguideline | Postguideline | Postguideline vs preguideline | |||||
---|---|---|---|---|---|---|---|---|
No. | Reoperation No. | Reoperation % (95% CI) | No. | Reoperation No. | Reoperation% (95% CI) | Difference in % (95% CI) | Odds ratio (95% CI) | |
Actual change in reoperation | ||||||||
Bhutani et al,15 2018 | 126 | 46 | 36.5 (28.1 to 45.5) | 111 | 10 | 9.0 (4.4 to 15.9) | −27.5 (−37.5 to −17.5) | 0.17 (0.08 to 0.36) |
Cate et al,162015 | 102 | 11 | 10.8 (4.8 to 16.8) | 103 | 1 | 1.0 (0.0 to 5.3) | −9.8 (−16.1 to −3.5) | 0.08 (0.01 to 0.64) |
Chavez-MacGreggor et al,17 2018 | 20 159 | 5100 | 25.3 (24.7 to 25.9) | 13 807 | 2982 | 21.6 (20.9 to 22.3) | −3.7 (−4.6 to −2.8) | 0.81 (0.77 to 0.86) |
Chung et al,18 2015 | 597 | 115 | 19.3 (16.1 to 22.4) | 249 | 32 | 12.9 (8.7 to 17.0) | −6.4 (−11.6 to −1.2) | 0.62 (0.40 to 0.94) |
Drohan et al,19 2018 | 188 | 26 | 13.8 (9.2 to 19.6) | 411 | 32 | 7.8 (5.4 to 10.8) | −6.0 (−11.6 to −0.5) | 0.53 (0.30 to 0.91) |
Heelan Gladden et al,20 2017 | 395 | 42 | 10.6 (7.8 to 14.1) | 286 | 29 | 10.1 (6.9 to 14.2) | −0.5 (−5.1 to 4.1) | 0.95 (0.58 to 1.56) |
Heidrich et al,21 2016 | 124 | 40 | 32.3 (24.1 to 41.2) | 42 | 1 | 2.4 (0.1 to 12.6) | −29.9 (−39.3 to −20.5) | 0.05 (0.01 to 0.39) |
Israel et al,23 2018 | 110 | 22 | 20.0 (13.0 to 28.7) | 150 | 20 | 13.3 (8.3 to 19.8) | −6.7 (−15.9 to 2.6) | 0.62 (0.32 to 1.19) |
Jiwa et al,24 2015 | 225 | 48 | 21.3 (16.2 to 27.3) | 238 | 32 | 13.4 (9.4 to 18.5) | −7.9 (−14.8 to −1.0) | 0.57 (0.35 to 0.94) |
Kantor et al,37 2019a | 402 678 | NR | NR | 118 900 | NR | NR | −3.6 (NR) | 0.76 (0.75 to 0.78) |
Mamtani et al,40 2019 | 312 | 98 | 31.4 (26.3 to 36.9) | 433 | 100 | 23.1 (19.2 to 27.4) | −8.3 (−14.8 to −1.8) | 0.66 (0.47 to 0.91) |
Monaghan et al,39 2019 | 523 | 118 | 22.6 (19.1 to 26.4) | 589 | 110 | 18.7 (15.6 to 22.1) | −3.9 (−8.7 to 0.9) | 0.79 (0.59 to 1.05) |
Morrow et al,26 2017b | 851 | 232 | 27.3 (24.3 to 30.4) | 1125 | 205 | 18.2 (16.0 to 20.6) | −9.0 (−12.8 to −5.3) | 0.59 (0.48 to 0.74) |
Parma et al,28 2018 | 15 | 3 | 20.0 (4.3 to 48.1) | 85 | 11 | 12.9 (6.6 to 22.0) | −7.1 (−28.5 to 14.4) | 0.59 (0.14 to 2.45) |
Patten et al,29 2017 | 402 | 82 | 20.4 (16.6 to 24.7) | 552 | 90 | 16.3 (13.3 to 19.7) | −4.1 (−9.1 to 0.1) | 0.76 (0.55 to 1.06) |
Pawloski et al,30 2016 | 123 | 42 | 34.1 (25.8 to 43.2) | 148 | 34 | 23.0 (16.5 to 30.6) | −11.2 (−21.9 to −0.4) | 0.58 (0.34 to 0.98) |
Philpott et al,41 2018 | 204 | 51 | 25.0 (19.2 to 31.5) | 358 | 59 | 16.5 (12.8 to 20.7) | −8.5 (−15.6 to −1.4) | 0.59 (0.39 to 0.90) |
Rosenberger et al,32 2016 | 504 | 108 | 21.4 (17.9 to 25.3) | 701 | 106 | 15.1 (12.5 to 18.0) | −6.3 (−10.8 to −1.9) | 0.65 (0.49 to 0.88) |
Schulman et al,33 2017c | 13 297 | 2482 | 18.7 (18.0 to 19.3) | 12 805 | 1851 | 14.5 (13.9 to 15.1) | −4.2 (−5.1 to −3.3) | 0.74 (0.69 to 0.79) |
Van Den Bruele et al,38 2018 | 116 | 23 | 19.8 (13.0 to 28.3) | 85 | 13 | 15.3 (8.4 to 24.7) | −4.5 (−15.1 to 6.0) | 0.73 (0.35 to 1.54) |
Wall et al,36 2015 | 53 | 7 | 13.2 (5.5 to 25.3) | 66 | 12 | 18.2 (9.8 to 29.6) | 5.0 (−8.1 to 18.0) | 1.46 (0.53 to 0.74) |
Projected change in reoperation | ||||||||
Baliski and Pataky,14 2017 | 512 | 126 | 24.6 (20.9 to 28.6) | 512 | 82 | 16.0 (12.9 to 19.5) | −8.6 (−11.1 to −0.1) | 0.58 (0.50 to 0.68) |
Bell,43 2018 | 417 | 78 | 18.7 (15.1 to 22.8) | 417 | 62 | 14.8 (11.6 to 18.7) | −3.8 (−5.7 to −2.0) | 0.76 (0.66 to 0.87) |
Hogan et al,22 2014 | 450 | 111 | 24.7 (20.7 to 28.9) | 450 | 70 | 15.6 (12.2 to 18.9) | −9.1 (−11.8 to −6.5) | 0.56 (0.47 to 0.67) |
Merrill et al,25 2016 | 437 | 139 | 31.8 (27.5 to 36.4) | 437 | 77 | 17.6 (14.2 to 21.5) | −14.2 (−17.5 to −10.9) | 0.46 (0.38 to 0.55) |
Nayyar et al,27 2018 | 436 | 143 | 32.8 (28.4 to 37.4) | 436 | 56 | 12.8 (9.9 to 16.3) | −19.9 (−23.7 to −16.2) | 0.30 (0.24 to 0.38) |
Pickard et al,31 2015 | 317 | 62 | 19.6 (15.3 to 24.4) | 317 | 55 | 17.4 (13.3 to 22.0) | −2.2 (−3.8 to −0.1) | 0.86 (0.78 to 0.96) |
Singer et al,34 2016 | 462 | 149 | 32.3 (28.0 to 36.7) | 462 | 88 | 19.0 (15.6 to 22.9) | −13.2 (−16.3 to −10.1) | 0.49 (0.42 to 0.58) |
Tang et al,35 2017 | 2858 | 493 | 17.2 (15.9 to 18.7) | 2858 | 441 | 15.4 (14.1 to 16.8) | −1.8 (−2.3 to −1.3) | 0.88 (0.84 to 0.91) |
Truda,42 2019 | 779 | 102 | 13.1 (10.8 to 15.7) | 779 | 50 | 6.4 (4.8 to 8.4) | −6.7 (−8.4 to −4.9) | 0.46 (0.37 to 0.56) |
Preguideline and postguideline numerators and percentages were not reported (NR) in the publication.
Data provided by study authors.
Preguideline and postguideline percentages were derived from numerators and denominators reported in the publication (these differ from the reported percentages).